Work

Preliminary preclinical study of Chol-DsiRNA polyplexes formed with PLL[30]-PEG[5K] for the RNAi-based therapy of breast cancer

Year: 2021

Type: article

Source: Nanomedicine Nanotechnology Biology and Medicine

DOI: 10.1016/j.nano.2021.102363

Authors: Zhen Ye, Mai Mohamed Abdelmoaty, Vishakha V. Ambardekar, Stephen M. Curran, Shetty Ravi Dyavar, Lora L. Arnold, Samuel M. Cohen, Devendra Kumar, Yazen Alnouti, Don W. Coulter, Rakesh K. Singh, Joseph A. Vetro

Institutions: University of Nebraska Medical Center, National Research Centre

Language: English

Topic: RNA Interference and Gene Delivery

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: University of Nebraska Medical Center, University of Nebraska-Lincoln, National Institutes of Health, National Institute on Drug Abuse, National Cancer Institute, National Institute of Allergy and Infectious Diseases, National Center for Advancing Translational Sciences

Awards: NanoART Manufacture, Delivery and Pharmacokinetics for Optimizing Drug Adherence, EP67-Based Targeted Mucosal Vaccines to Prevent Primary Infection with CMV, Targeting CXCR2 axis in Pancreatic Cancer, Development of Chol-DsiRNA Polyplexes to Improve the Therapy of Breast Cancer, Buffett Cancer Center Support Grant

OpenAlex ID: W3126644485

FWCI: 0.314

Cites: 35

Cited by: 5

Related to: 10